- $21.14bn
- $22.63bn
- $12.14bn
- 72
- 56
- 92
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 7,902 | 8,099 | 9,455 | 11,166 | 12,143 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,927 | 7,243 | 8,051 | 9,367 | 10,229 |
Operating Profit | 976 | 856 | 1,404 | 1,799 | 1,914 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 853 | 705 | 1,283 | 1,720 | 1,754 |
Provision for Income Taxes | |||||
Net Income After Taxes | 684 | 533 | 1,031 | 1,385 | 1,384 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 682 | 531 | 1,022 | 1,381 | 1,381 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 682 | 531 | 1,022 | 1,381 | 1,381 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 1.57 | 2.57 | 4.96 | 5.06 |
Dividends per Share | |||||
Special Dividends per Share |